BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fenofibrate
,
rs2300478
,
FXYD4
,
Response to oxidative stress
,
Obesity
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ep inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Neuroblastoma SHEP cells with dox-induced/uninduced MYCN before or after nutlin-3a treatment
Heart ventricle from salt-sensitive rats on a high-salt diet treated with paricalcitol and enalapril
Hepatocytes treated with non-genotoxic carcinogens
Breast adenocarcinoma MCF7 cells with doxycycline-induced ESR1 Y537S mutation and treated with THZ1
Hematopoietic stem and progenitor cells from healthy donors treated with valproic acid
Explore Curated Studies Results
Literature
Most Relevant Literature
m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS).
Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-…
Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposi…
In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated hepari…
Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previou…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients
Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Sub…
Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC
Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS
A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ